PDE5A inhibition attenuates cardiac hypertrophy and hypertrophy signaling cascades in vivo

被引：0
|
作者：
Takimoto, E
Champion, HC
Li, MX
Belardi, DF
Ren, SX
Wang, YB
Kass, DA
机构：
[1] Johns Hopkins Univ, Inst Med, Baltimore, MD USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
298
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [1] Suppressing cardiac hypertrophy with PDE5a inhibition
    Kass, DA
    Champion, HC
    Li, MX
    Belardi, D
    Takimoto, E
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 870 - 871
  • [2] PDE5A inhibition suppresses maldative but not physiological cardiac hypertrophy
    Mulhearn, Thomas J.
    El-Haddad, Hazim
    Mahmud, Mobusher
    Gebska, Milena
    Bridges, Michael
    Bedja, Djahida
    Gabrielson, Kathy
    Hemnes, Anna R.
    Kass, David A.
    Champion, Hunter C.
    CIRCULATION RESEARCH, 2006, 99 (05) : E23 - E23
  • [3] PDE5A inhibition suppresses maladaptive but not physiological cardiac hypertrophy
    Mulheam, Thomas J.
    El-Haddad, Hazim
    Mahmud, Mobusher
    Gebska, Milena
    Haile, Azeb
    Bridges, Michael
    Bedja, Djahida
    Gabrielson, Kathy
    Hemnes, Anna R.
    Kass, David A.
    Champion, Hunter C.
    CIRCULATION, 2006, 114 (18) : 5 - 5
  • [4] Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
    De Windt, LJ
    Lim, HW
    Bueno, OF
    Liang, QR
    Delling, U
    Braz, JC
    Glascock, BJ
    Kimball, TF
    del Monte, F
    Hajjar, RJ
    Molkentin, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3322 - 3327
  • [5] PDE5 Inhibition Counteracts β-Adrenergic Induction Of Cardiac Hypertrophy
    Di Grazia, A.
    Cornacchione, M.
    Zevini, A.
    Aguanno, S.
    De Arcangelis, V
    Pellegrini, M.
    Barbagallo, F.
    Isidori, A.
    Monaco, L.
    Naro, F.
    XXII INTERNATIONAL SYMPOSIUM ON MORPHOLOGICAL SCIENCES (ISMS), 2012, : 125 - 131
  • [6] Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway
    Xing Chen
    Xingzuan Jiang
    Chuanfang Cheng
    Jing Chen
    Shuyan Huang
    Miqing Xu
    Shiming Liu
    Cardiovascular Drugs and Therapy, 2020, 34 : 463 - 473
  • [7] Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway
    Chen, Xing
    Jiang, Xingzuan
    Cheng, Chuanfang
    Chen, Jing
    Huang, Shuyan
    Xu, Miqing
    Liu, Shiming
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 463 - 473
  • [8] cGMP kinase I, cardiac hypertrophy and PDE inhibition
    Patrucco, E.
    Domes, K.
    Lukowski, R.
    Rybalkin, S.
    Hofmann, F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 68 - 68
  • [9] PDE5A Inhibition in Burn-induced Cardiac Dysfunction
    Wen, Jake J.
    Radhakrishnan, Ravi S.
    CIRCULATION RESEARCH, 2020, 127
  • [10] Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro
    Meng, Y.
    Zhang, Y.
    Ma, Z.
    Zhou, H.
    Ni, J.
    Liao, H.
    Tang, Q.
    HERZ, 2019, 44 (03) : 247 - 256
12345